Memantine Blocks α7* Nicotinic Acetylcholine Receptors More Potently Than N-Methyl-D-aspartate Receptors in Rat Hippocampal Neurons

@article{Aracava2005MemantineB,
  title={Memantine Blocks $\alpha$7* Nicotinic Acetylcholine Receptors More Potently Than N-Methyl-D-aspartate Receptors in Rat Hippocampal Neurons},
  author={Y. Aracava and E. Pereira and A. Maelicke and E. Albuquerque},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2005},
  volume={312},
  pages={1195 - 1205}
}
The N-methyl-d-aspartate (NMDA) receptor antagonist memantine is an approved drug for treatment of Alzheimer's disease (AD). Other such treatments are cholinesterase inhibitors and nicotinic acetylcholine receptor (nAChR)-sensitizing agents such as galantamine. The present study was designed to test whether memantine exerts any effect on the cholinergic system, in particular the Ca2+-conducting α7* nAChR, in cultured hippocampal neurons. Memantine caused a concentration-dependent reduction of… Expand
View on ASPET
jpet.aspetjournals.org
152 Citations
Highly Influential Citations
10
Background Citations
45
Methods Citations
4
Results Citations
4

152 Citations

Citation Type

Citation Type

Activation of Brain Histaminergic Neurotransmission: A Mechanism for Cognitive Effects of Memantine in Alzheimer's Disease
Memantine Inhibits ATP-Dependent K+ Conductances in Dopamine Neurons of the Rat Substantia Nigra Pars Compacta
Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats
Cholinergic direct inhibition of N‐methyl‐D aspartate receptor‐mediated currents in the rat neocortex
Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse
Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology
  • M. Pohanka
  • Medicine
  • International journal of molecular sciences
  • 2012
Memantine Inhibits α3β2-nAChRs-Mediated Nitrergic Neurogenic Vasodilation in Porcine Basilar Arteries
Pharmacology of Acetylcholinesterase Inhibitors and N‐methyl‐d‐aspartate Receptors for Combination Therapy in the Treatment of Alzheimer's Disease
Mechanism of block and behavioral effects of the N-methyl-D-aspartate receptor antagonists memantine and ketamine
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 55 REFERENCES
Inhibition of human α7 nicotinic acetylcholine receptors by open channel blockers of N‐methyl‐D‐aspartate receptors
Open-Channel Blockers at the Human α4β2 Neuronal Nicotinic Acetylcholine Receptor
The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence
The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.
Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes.
Memantine restores long term potentiation impaired by tonic N-methyl-d-aspartate (NMDA) receptor activation following reduction of Mg2+ In hippocampal slices
Memantine inhibits efferent cholinergic transmission in the cochlea by blocking nicotinic acetylcholine receptors of outer hair cells.
Mechanism of memantine block of NMDA‐activated channels in rat retinal ganglion cells: uncompetitive antagonism.
Choline and acetylcholine have similar kinetic properties of activation and desensitization on the α7 nicotinic receptors in rat hippocampal neurons
Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man
...
1
2
3
4
5
...